| Autor: |
Chinchilla-Tábora, Luis Miguel, Rodríguez-Parets, Javier Ortiz, Otero-Rodríguez, Álvaro, Martín, Laura Ruiz, Escudero, Juan Carlos Paniagua, Martín, Luis Miguel Navarro, García, Belén Cigarral, Palacios, Adelaida Nieto, Morais, Idalia González, Sayagués, José María, Cruz, María Dolores Ludeña de la |
| Předmět: |
|
| Zdroj: |
International Medical Case Reports Journal; Nov2023, Vol. 16, p709-714, 6p |
| Abstrakt: |
Hemangioblastoma (HB) is a Central Nervous System (CNS) tumor with a generally favorable behavior and prognosis, classified as WHO grade 1. Sporadic HB is not related to any inherited disease, and it usually appears in a single location. Sporadic or VHL-related HBs show variable patterns of growth velocity. Cases of growing HB can cause mild symptoms such as headache, but some cases develop serious complications such as accumulation of cerebrospinal fluid in the brain with secondary neurological damage sometimes being irreversible when early treatment is not started. Our case showed some clinical characteristics more frequently observed in VHL-related HB rather than sporadic HB, and the presence of alterations in MDM2 and EGFR that could be related to the oncogenesis of these tumors. Even when the treatment of choice for HB is surgery, the presence of these genetic alterations could open a new window for research aimed at assessing the possibility of new therapies with TKIs-EGFR and anti-MDM2 inhibitors in those HB cases with multifocal recurrences or cases with an adverse clinical behavior. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
